Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.51 |
| ▸ | NR5A2 | O00482 | 1/20 | 0.51 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.51 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | CNR1 | P21554 | 1/20 | 0.46 |
| ▸ | CNR2 | P34972 | 1/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | ESR1 | P03372 | 1/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.45 |
| ▸ | CDC25A | P30304 | 1/20 | 0.45 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.45 |
| ▸ | AKT1 | P31749 | 1/20 | 0.45 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4619498 | 1.00 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479610 | 1.00 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL4619726 | 1.00 | ALDH1A1 (0.64) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL1576782 | 0.99 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL2561609 | 0.99 | ALDH1A1 (0.66) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL37559 | 0.97 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL671456 | 0.97 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479222 | 0.97 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL672371 | 0.97 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 | |
| SCHEMBL479198 | 0.97 | ALDH1A1 (0.60) | ALDH1A1SMN1; SMN2NR5A2NR5A1S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4695401-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | Strand Therapeutics Inc. (US) | 2026-02-18 | — | — | EP | disclosed |
| EP-4490519-A1 | LIPOSOME-CONTAINING DIAGNOSTIC REAGENTS AND METHODS OF PRODUCTION AND USE THEREOF | Siemens Healthcare Diagnostics, Inc. (US) | 2025-01-15 | — | — | EP | disclosed |
| WO-2024216162-A1 | SYNTHETIC CIRCUITS AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2024-10-17 | — | — | WO | disclosed |
| WO-2023240261-A1 | NUCLEOBASE EDITING SYSTEM AND METHOD OF USING SAME FOR MODIFYING NUCLEIC ACID SEQUENCES | RENAGADE THERAPEUTICS MANAGEMENT INC. (US) | 2023-12-14 | — | — | WO | disclosed |
| WO-2023212618-A1 | LIPID NANOPARTICLES COMPRISING VENEZUELAN EQUINE ENCEPHALITIS (VEE) REPLICON AND USES THEREOF | STRAND THERAPEUTICS INC. (US) | 2023-11-02 | — | — | WO | disclosed |
| WO-2023172812-A1 | LIPOSOME-CONTAINING DIAGNOSTIC REAGENTS AND METHODS OF PRODUCTION AND USE THEREOF | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2023-09-14 | — | — | WO | disclosed |
| EP-4114968-A1 | COMPOSITIONS AND METHODS OF USING MODIFIED LIPOSOMES | Siemens Healthcare Diagnostics, Inc. (US) | 2023-01-11 | — | — | EP | disclosed |
| WO-2022040435-A1 | NANODRUGS FOR TARGETED DRUG DELIVERY AND USE THEREOF | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2022-02-24 | — | — | WO | disclosed |
| WO-2021178987-A1 | COMPOSITIONS AND METHODS OF USING MODIFIED LIPOSOMES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2021-09-10 | — | — | WO | disclosed |
| EP-3856149-A1 | COMPOSITIONS AND METHODS FOR REMOVING INTERFERING SUBSTANCES | Siemens Healthcare Diagnostics, Inc. (US) | 2021-08-04 | — | — | EP | disclosed |
| WO-2020068609-A1 | COMPOSITIONS AND METHODS FOR REMOVING INTERFERING SUBSTANCES | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2020-04-02 | — | — | WO | disclosed |
| EP-2654779-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | Ludwig Institute for Cancer Research, Ltd. (US) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012088414-A1 | LIPOSOMAL FORMULATION OF NONGLYCOSIDIC CERAMIDES AND USES THEREOF | LUDWIG INSTITUTE FOR CANCER RESEARCH LTD. (US) | 2012-06-28 | — | — | WO | disclosed |
| EP-2410990-A1 | COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING | Marval Biosciences, Inc. (US) | 2012-02-01 | — | — | EP | disclosed |
| WO-2010107990-A1 | COMPOSITIONS AND METHODS FOR ENHANCING CONTRAST IN IMAGING | MARVAL BIOSCIENCES, INC. (US) | 2010-09-23 | — | — | WO | disclosed |
| EP-2081552-A2 | SPONTANEOUSLY FORMING ELLIPSOIDAL PHOSPHOLIPID UNILAMELLAR VESICLES | Children's Hospital Medical Center (US) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008051818-A2 | SPONTANEOUSLY FORMING ELLIPSOIDAL PHOSPHOLIPID UNILAMELLAR VESICLES | CHILDREN'S HOSPITAL MEDICAL CENTER (US) | 2008-05-02 | — | — | WO | disclosed |
| US-20040161523-A1 | Method and compositions for producing berry derived products | MICHIGAN STATE UNIVERSITY (US) | 2004-08-19 | — | — | US | disclosed |
| WO-2000033670-A1 | METHOD AND COMPOSITIONS FOR PRODUCING BERRY DERIVED PRODUCTS | MICHIGAN STATE UNIVERSITY (US) | 2000-06-15 | — | — | WO | disclosed |